Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-035112
Filing Date
2015-02-05
Accepted
2015-02-05 13:44:03
Documents
2
Group Members
ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLCMPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES III GP, L.P.MPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND, L.P.MPM BIO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d868255dsc13ga.htm SC 13G/A 264907
2 EX-99.A d868255dex99a.htm EX-99.A 28835
  Complete submission text file 0001193125-15-035112.txt   296079
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III L.P. (Filed by) CIK: 0001173408 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Subject) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87188 | Film No.: 15579351
SIC: 2834 Pharmaceutical Preparations